TMCI

#3096
Treace Medical Concepts, Inc. - Common Stock
3.4 6 USD
+12.34%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
3.46
3.46
Faixa anual
1.17
7.78
Mudança diária
+12.34%
Mudança mensal
+95.48%
Mudança em 6 meses
+18.49%
Mudança anual
-40.45%
Fechamento anterior
3.0 8
Open
3.4 6
Mínimo
3.4 6
High
3.4 6
Volume
60
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Treace Medical Concepts, Inc. - Common Stock

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions. In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021.

Notícias